Printer Friendly

Breast cancer drug is lifesaver.

A NEWLYPRESCRIBED breast cancer drug is much more effective than a standard treatment, a study revealed yesterday.

Scotland became the first part of the UK this week to approve Arimidex for post-menopausal women with early breast cancer.

The drug, which has been hailed as the new gold standard therapy after surgery, will benefit around 4,000 women.

Patients in England and Wales could also get the drug before the end of the year.

It is due to be considered soon for approval by the National Institute for Clinical Excellence and become available.

Research published in the Lancet Oncology found women with early breast cancer who switched to Arimidex after using the standard drug Tamoxifen, for two to three years following surgery reduced chances of dying by 29%.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Features
Publication:Daily Post (Liverpool, England)
Date:Nov 17, 2006
Previous Article:City conservation may save heritage.
Next Article:Liverpool's 'jewel in the crown' synagogue at risk.

Related Articles
New hope raised for treatment of cancer.
New drug for cancer approved.
Volunteer for a vital clinical trial.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters